China proposes simpler medical-device re-registration rules

04/8/2013 | Clinica (subscription required)

The China Food and Drug Administration has proposed reducing the amount of information companies must submit to re-register medical products when no changes exist that would affect safety or efficacy. Certain applications would require no technical review, but applications involving significant changes that might affect product safety and efficacy would require a new product registration. The agency has also proposed a system to expedite approval of certain innovative medical devices, but it would apply only for devices made by companies licensed in China.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY